Cargando...
Nicotinamide mononucleotide attenuates glucocorticoid-induced osteogenic inhibition by regulating the SIRT1/PGC-1α signaling pathway
Long-term and high-dose glucocorticoid treatment is recognized as an important influencing factor for osteoporosis and osteonecrosis. Nicotinamide mononucleotide (NMN) is an intermediate of NAD(+) biosynthesis, and is widely used to replenish the levels of NAD(+). However, the potential role of NMN...
Guardado en:
| Publicado en: | Mol Med Rep |
|---|---|
| Autores principales: | , |
| Formato: | Artigo |
| Lenguaje: | Inglês |
| Publicado: |
D.A. Spandidos
2020
|
| Materias: | |
| Acceso en línea: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7248519/ https://ncbi.nlm.nih.gov/pubmed/32377728 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3892/mmr.2020.11116 |
| Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|